dimethylacetamide has been researched along with Hematologic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartelink, I; Boelens, J; Boos, J; Diestelhorst, C; Hempel, G; Kerl, K; Trame, MN | 1 |
| Andersson, BS; Blume, KG; Champlin, RE; Chow, DS; Hu, WW; Madden, T; Tran, HT; Vaughan, WP | 1 |
1 trial(s) available for dimethylacetamide and Hematologic Neoplasms
| Article | Year |
|---|---|
Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: a phase I study.
Topics: Acetamides; Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biological Availability; Busulfan; Cyclophosphamide; Drug Carriers; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Intestinal Absorption; Male; Middle Aged; Polyethylene Glycols; Safety; Solvents; Transplantation Conditioning | 2000 |
1 other study(ies) available for dimethylacetamide and Hematologic Neoplasms
| Article | Year |
|---|---|
Evaluation of effects of busulfan and DMA on SOS in pediatric stem cell recipients.
Topics: Acetamides; Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cryoprotective Agents; Female; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Infant; Male; Prognosis; Retrospective Studies; Risk Factors; Transplantation, Homologous; Young Adult | 2014 |